PEARL THERAPEUTICS INC has a total of 179 patent applications. It increased the IP activity by 150.0%. Its first patent ever was published in 2010. It filed its patents most often in Australia, United States and Republic of Korea. Its main competitors in its focus markets pharmaceuticals, medical technology and machines are VECTURA LTD, ADVANCED INHALATION RES INC and NEURODERM LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 19 | |
#2 | United States | 19 | |
#3 | Republic of Korea | 13 | |
#4 | China | 12 | |
#5 | Hong Kong | 12 | |
#6 | EPO (European Patent Office) | 11 | |
#7 | Brazil | 8 | |
#8 | Canada | 8 | |
#9 | Taiwan | 8 | |
#10 | Hungary | 7 | |
#11 | Israel | 7 | |
#12 | Japan | 7 | |
#13 | WIPO (World Intellectual Property Organization) | 7 | |
#14 | Mexico | 6 | |
#15 | South Africa | 5 | |
#16 | Argentina | 4 | |
#17 | Singapore | 4 | |
#18 | Slovenia | 3 | |
#19 | Costa Rica | 2 | |
#20 | Dominican Republic | 2 | |
#21 | Peru | 2 | |
#22 | Philippines | 2 | |
#23 | Chile | 1 | |
#24 | Colombia | 1 | |
#25 | Ecuador | 1 | |
#26 | Lithuania | 1 | |
#27 | Luxembourg | 1 | |
#28 | Montenegro | 1 | |
#29 | Nicaragua | 1 | |
#30 | Netherlands | 1 | |
#31 | Norway | 1 | |
#32 | New Zealand | 1 | |
#33 | Russian Federation | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Machines | |
#4 | Chemical engineering |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Syringes | |
#4 | Milling | |
#5 | Chemical or physical processes |
# | Name | Total Patents |
---|---|---|
#1 | Joshi Vidya B | 107 |
#2 | Vehring Reinhard | 106 |
#3 | Dwivedi Sarvajna Kumar | 102 |
#4 | Smith Adrian Edward | 88 |
#5 | Hartman Michael Steven | 88 |
#6 | Lechuga-Ballesteros David | 50 |
#7 | Dwivedi Sarvajna | 22 |
#8 | Reinhard Vehring | 19 |
#9 | Sarvajna Kumar Dwivedi | 17 |
#10 | Ferriter Matthew | 17 |
Publication | Filing date | Title |
---|---|---|
KR20200070284A | Drug delivery systems and related methods | |
CN108136144A | Aerosol delivery systems | |
AU2015201864A1 | Compositions for pulmonary delivery of long-acting muscarinic antagonists and long-acting B2 adrenergic receptor agonists and associated methods and systems | |
AU2015201221A1 | Compositions for respiratory delivery of active agents and associated methods and systems | |
AU2015201037A1 | Respiratory delivery of active agents | |
AU2014268482A1 | Compositions, methods and systems for respiratory delivery of three or more active agents | |
SG11201507286QA | Methods and systems for conditioning of particulate crystalline materials | |
US2013092160A1 | Compositions, methods and propellant-based systems for respiratory delivery of glycopyrrolate and one or more active agents | |
CN103687483A | Compositions, methods & systems for respiratory delivery of two or more active agents | |
CN105106200A | Compositions, methods and systems for respiratory delivery of two or more active agents | |
MX2011012685A | Compositions for pulmonary delivery of long-acting muscarinic antagonists and long-acting b2 adrenergic receptor agonists and associated methods and systems. |